Nasus Pharma Ltd (NSRX) revenue & profit
Nasus Pharma Ltd (NSRX): revenue $1.2B, net income -$5.9M in 2025; latest quarter – year over year. From SEC filings.
$1.2BRevenue 2025
TickerNSRX (NYSE)
IndustryOther
Revenue 2025$1.2B
Net income 2025-$5.9M
Net margin-0.5%
Annual revenue growth–
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2025 | $1.2B | -$5.9M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.